[1] |
孙可欣,郑荣寿,张思维,等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤,2019,28(1):1-11.
|
[2] |
LIN C L,KAO J H.Risk stratification for hepatitis B virus related hepatocellular carcinoma[J]. J Gastroenterol Hepatol,2013,28(1):10-17.
|
[3] |
TZARTZEVA K,OBI J,RICH N E,et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis:a meta-analysis[J]. Gastroenterology,2018,154(6):1706-1718.e1.
|
[4] |
PINHO S S,REIS C A.Glycosylation in cancer:mechanisms and clinical implications[J]. Nat Rev Cancer,2015,15(9):540-555.
|
[5] |
ISHIKAWA T,YONEYAMA T,TOBISAWA Y,et al.An automated micro-total immunoassay system for measuring cancer-associated α2,3-linked sialyl N-glycan-carrying prostate-specific antigen may improve the accuracy of prostate cancer diagnosis[J]. Int J Mol Sci,2017,18(2):470.
|
[6] |
ZHANG S,SHANG S,LI W,et al.Insights on N-glycosylation of human haptoglobin and its association with cancers[J]. Glycobiology,2016,26(7):684-692.
|
[7] |
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华消化外科杂志,2017,16(7):635-647.
|
[8] |
王贵强,王福生,成军,等. 慢性乙型肝炎防治指南(2015年版)[J]. 中华实验和临床感染病杂志(电子版),2015,9(5):570-589.
|
[9] |
ZHAO Y,LI Y,MA H,et al.Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma[J]. Mol Cell Proteomics,2014,13(2):520-536.
|
[10] |
XU J,LIN Y,WANG Y P,et al.Hepatitis B virus DNA in patients with hepatitis B-related liver cirrhosis with or without hepatocellular carcinomas:a matched case-control study[J]. J Dig Dis,2009,10(2):138-144.
|
[11] |
LI Y,ZHANG Z,SHI J,et al.Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China[J]. Int J Clin Exp Med,2015,8(1):1205-1212.
|
[12] |
ANG I L,POON T C,LAI P B,et al.Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma:a glycoproteomic approach[J]. J Proteome Res,2006,5(10):2691-2700.
|
[13] |
HUANG Y,ZHOU S,ZHU J,et al.LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma(HCC)and cirrhotic patients[J]. Electrophoresis,2017,38(17):2160-2167.
|
[14] |
HAN L L,LV Y,GUO H,et al.Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy[J]. World J Gastroenterol,2014,20(30):10249-10261.
|
[15] |
LEI Z,LI J,WU D,et al.Nomogram for Preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria[J]. JAMA Surg,2016,151(4):356-363.
|